MV
Morningside Ventures
Hong KongFounded 1986
Morningside Ventures focuses on early-stage investments in companies with novel science and technology, particularly across life sciences, digital health, AI, materials, and broader technology sectors. Their strategy involves a long-term outlook in company-building, active partnership with founders, and a commitment to ethical practices.
36% of their portfolio is in Healthcare. Deal activity increased 100% year-over-year (4 deals in the last 12 months). Average disclosed round size is $64.2M (across 46 rounds with reported amounts).
Portfolio
50
Fund Size
$2.2B
Top Stage
Series B
Last 12 Mo
4
Team
IC
Isaac Cheng
Analyst
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
50 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Series A | $10.8M | Apr 2026 | |
| Seed | $8.5M | Oct 2025 | |
| Series B | $28M | Oct 2025 | |
| CCyted Health | Series B | $44M | Sep 2025 |
| Series B | $12M | Mar 2025 | |
| Seed | $4M | Feb 2025 | |
| Series B | $30M | Dec 2023 | |
| Series A | $32M | Aug 2023 | |
| Series A | $15M | Nov 2022 | |
| VValitor, Inc. | Series B | $28M | Oct 2022 |
| PPsycApps | Seed | $1.7M | Sep 2022 |
| EEpigenic Therapeutics Co., Ltd. | Series A | $20M | Aug 2022 |
| Seed | $6M | May 2022 | |
| Seed | — | Mar 2022 | |
| Series A | $12M | Feb 2022 | |
| Series B | $30M | Jan 2022 | |
| Series C | $50M | Nov 2021 | |
| Series A | $12.5M | Nov 2021 | |
| Series D | $100M | Sep 2021 | |
| Series B | $25M | Jul 2021 | |
| Series A | $40M | May 2021 | |
| NNeuroelectrics | Series A | $17.5M | May 2021 |
| Series B | $30M | Apr 2021 | |
| Series B | $100M | Mar 2021 | |
| Series B | $27.5M | Dec 2020 |
Page 1 of 2
Top Co-Investors
Shunwei Capital5 shared
General Catalyst4 shared
SIG3 shared
Lightspeed Venture Partners3 shared
IDG Capital3 shared
ADvantage2 shared
Tencent Investment2 shared
Elizabeth Street2 shared
SoftBank Vision Fund2 shared
Sequoia China2 shared
Matrix Partners China2 shared
Coatue Management2 shared
University Growth Fund2 shared
Matrix Partners2 shared
DCM Ventures2 shared
Viewside Capital Partners1 shared
Alpha Wave Global1 shared
Sectoral Asset Management1 shared
New World Development1 shared
Nan Fung Life Sciences1 shared
Last updated: 12 April 2026